Elevance Health Stock - Institutional investors add positions as consensus stays Moderate Buy

Elevance Health attracts fresh institutional interest, while analysts maintain a Moderate Buy consensus and a solid upside to their average target. A midweek check also shows where the stock stands versus key healthcare peers.

Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/17/2026, 17:46 CET. Details in the imprint.

Elevance Health (US2855211023) is seeing fresh interest from institutional investors alongside a stable analyst stance. Recent filings and analyst data compiled by MarketBeat show additional fund positions and a consensus rating of "Moderate Buy" on the stock .

What recent filings show

According to a MarketBeat report on 06/17/2026, Persistent Asset Partners and Rakuten Investment Management disclosed fresh or increased positions in Elevance Health, signaling continued institutional appetite for the stock .

The same report notes that Elevance Health reported earnings per share of $12.58 on revenue of $49.49 billion in its latest quarter, with both metrics coming in above analyst expectations . That backdrop helps explain why large funds remain engaged with the name .

Analyst stance and sector context

Across Wall Street, 14 research analysts rate Elevance Health stock as a Buy and nine as a Hold, for an overall "Moderate Buy" consensus, based on MarketBeat data . The average price target currently stands at $416.11 per share .

This implies a modest upside from the recent trading range and situates Elevance Health among the higher-rated US managed care stocks by consensus. MarketBeat data also highlight the company's market capitalization of around $86.3 billion and a price-to-earnings ratio near 16.9, which is in line with large healthcare peers .

The product behind the stock

Elevance Health generates most of its revenue from commercial and government-backed health insurance plans under brands such as Anthem Blue Cross and Blue Shield, alongside specialty offerings like pharmacy benefits and care management services.

Where the stock trades today

Elevance Health shares (US2855211023) trade on the New York Stock Exchange at $397.53 as of 06/17/2026, 17:30 CET, according to recent quote data .

Key facts on Elevance Health stock

• Company: Elevance Health, Inc.
• ISIN: US2855211023
• WKN: A3DMT9
• Ticker: ELV
• Venue: NYSE
• Price (as of 06/17/2026, 17:30 CET): 397.53 USD
• Market cap: 86.33 billion USD (as of 06/17/2026)
• Sector / Industry: Health Care / Managed Health Care
• Index membership: Standard & Poor's 500 index
• Next earnings date: 07/17/2026

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.